FNDC5 and hepatocellular carcinoma: It is important to note that one study showed no effects of irisin on cancer cell proliferation [76], while another study utilizing hepatocellular carcinoma cells showed increased proliferation, migration and invasion with irisin treatment [84] that was associated with activation of the PI3K/Akt signaling pathway.